MyAverix Finance
HK · Healthcare
Lee’s Pharmaceutical Holdings Ltd (0950)
Drug Manufacturers - Specialty & Generic
Lee’s Pharmaceutical Holdings Ltd (0950) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $653.61M, P/E ratio is 6.94, net margin is 6.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 0950
Lee’s Pharmaceutical Holdings Ltd (0950) — FAQ
What is Lee’s Pharmaceutical Holdings Ltd's market cap?
Lee’s Pharmaceutical Holdings Ltd (0950) has a reported market cap of $653.61M (data as of 2026-05-21).
What is 0950's P/E ratio?
The price-to-earnings (P/E) ratio for Lee’s Pharmaceutical Holdings Ltd (0950) is 6.94 (data as of 2026-05-21).
Does Lee’s Pharmaceutical Holdings Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Lee’s Pharmaceutical Holdings Ltd (0950). Check the MyAverix Finance app for the latest dividend data.
What sector is Lee’s Pharmaceutical Holdings Ltd in?
Lee’s Pharmaceutical Holdings Ltd (0950) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 0950 listed on?
0950 is listed on HK.
What is Lee’s Pharmaceutical Holdings Ltd's net margin?
Lee’s Pharmaceutical Holdings Ltd (0950) reports a net margin of 6.4% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.